Durvalumab +/- tremelimumab plus platinum-etoposide in first-line (1L) extensive-stage SCLC (ES-SCLC): Results from the phase 3 CASPIAN study
Author
Trukhin, D.
Grohe, C.
Paz-Ares, L. G.
Dvorkin, M.
Chen, Y.
Hotta, K.
Statsenko, G.
Hochmair, M. J.
ÖZGÜROĞLU, Mustafa
Ji, J. H.
Voitko, O.
Poltoratskiy, A.
Verderame, F.
Havel, L.
Bondarenko, I.
Armstrong, J.
Byrne, N.
Jiang, H.
Goldman, J. W.
Reinmuth, N.
Metadata
Show full item recordCollections
- Makale [92796]